Use of Computed Tomography and Positron Emission Tomography/Computed Tomography for Staging of Local Extent in Patients With Malignant Pleural Mesothelioma-Reference-Cited by-同舟云学术

Use of Computed Tomography and Positron Emission Tomography/Computed Tomography for Staging of Local Extent in Patients With Malignant Pleural Mesothelioma

Published:2015 Issue:2 Volume:39 Page:160-165
ISSN:0363-8715
Container-title:Journal of Computer Assisted Tomography
language:en
Short-container-title:Journal of Computer Assisted Tomography

Author:

Frauenfelder Thomas,Kestenholz Peter,Hunziker Roger,Nguyen Thi Dan Linh,Fries Martina,Veit-Haibach Patrick,Husmann Lars,Stahel Rolf,Weder Walter,Opitz Isabelle

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging

Reference25 articles.

1. Malignant Pleural Mesothelioma: Role of CT, MRI, and PET/CT in Staging Evaluation and Treatment Considerations

2. Morphologic and functional imaging of malignant pleural mesothelioma

3. Computed Tomography, Positron Emission Tomography, Positron Emission Tomography/Computed Tomography, and Magnetic Resonance Imaging for Staging of Limited Pleural Mesothelioma

4. Imaging in pleural mesothelioma: A review of the 11th International Conference of the International Mesothelioma Interest Group

5. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease;Cancers;2023-12-06

2. Comparison of the role of 18F-fluorodeoxyglucose PET/computed tomography and 68Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma;Nuclear Medicine Communications;2023-04-28

3. B. Malignant Pleural Mesothelioma;Airway diseases;2023

4. The Prognostic Value of 18F-FDG PET Imaging at Staging in Patients with Malignant Pleural Mesothelioma: A Literature Review;Journal of Clinical Medicine;2021-12-22

5. “PET/CT Variants and Pitfalls in Lung Cancer and Mesothelioma”;Seminars in Nuclear Medicine;2021-09